氟康唑和伏立康唑对酵母菌抗菌活性的研究

被引:24
作者
徐英春
王澎
原英
谢秀丽
张月贤
刘娟
陈民钧
机构
[1] 中国医学科学院北京协和医院检验科
关键词
抗真菌药; 微生物敏感试验; 酵母菌;
D O I
10.16718/j.1009-7708.2003.05.005
中图分类号
R96 [药理学];
学科分类号
100602 ; 100706 ;
摘要
目的 :研究氟康唑和伏立康唑对 2 14株酵母菌的体外抗菌活性。方法 :酵母菌收集自 2 0 0 0年 1月至 2 0 0 1年 12月住院患者提供的标本。采用酵母菌纸片扩散法敏感试验 ,Mueller Hinton琼脂中补充 2 %葡萄糖和 0 .5mg/L美蓝 ,其他类似于美国国家临床实验室标准委员会 (NCCLS)M2 A6细菌药敏试验法。采用BIOMIC仪自动读取平皿抑菌环直径、解释和记录试验结果及核对质控数据。结果 :白念珠菌最常见 ,占 5 4 .7% ,其次为热带念珠菌占 18.7% ,光滑念珠菌占 12 .1% ,近平滑念珠菌占 4 .7% ,克柔念珠菌占 3.7%和新型隐球菌占 3.7%。白念珠菌、热带念珠菌和近平滑念珠菌对氟康唑的敏感率为 92 .5 %~10 0 .0 % ,MIC90 均在敏感范围内 (<3~ 8mg/L) ,伏立康唑对白念珠菌、热带念珠菌、光滑念珠菌和近平滑念珠菌的MIC90 为 0 .0 6 4~ 1.5mg/L。结论 :氟康唑对白念珠菌、热带念珠菌和近平滑念珠菌有较好的抗菌活性 ,伏立康唑比氟康唑对白念珠菌、热带念珠菌、光滑念珠菌和近平滑念珠菌有更高的抗菌活性 ,有较低的MIC值
引用
收藏
页码:277 / 279
页数:3
相关论文
共 10 条
  • [1] Comparison of efficacy and cost-effectiveness of BIOMIC video and Vitek antimicrobial susceptibility test systems for use in the clinical microbiology laboratory. Berke I,Tierno PM Jr. Journal of Clinical Microbiology . 1996
  • [2] Method for antifungal disk diffusion susceptibility testing of yeasts; proposed guideline. National Committee for Clinical Laboratory Standards. . 2003
  • [3] Nosocomialbloodstream infectionsinUnitedStateshospitals:athree-yearanalysis. EdmondMB,WallaceSE,McClishDK,etal. Clinical Infectious Diseases . 1999
  • [4] International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program. Pfaller MA,Jones RN,Doern GV,et al. Journal of Clinical Microbiology . 1998
  • [5] The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients. Paterson PJ,McWhinney PH,Potter M,et al. British Journal of Haematology . 2001
  • [6] The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients. Paterson PJ,McWhinney PH,Potter M,et al. British Journal of Haematology . 2001
  • [7] Antifungaldrugresistance:doesitmatter?. RogersTR. InternationalJournalofInfectiousDiseases . 2002
  • [8] Fungi,Aguidetoinfectioncontrolinthehospitalinternationalsocietyforinfectiondiseases. WenzelR,BrewerTF,ButzlerJP ,etal. . 2002
  • [9] National Epidemi ologyofMycosesSurvey.VariationsinratesofCandidaBloodstreamIn fectionsduetocandidaspeciesinSevensurgicalICUsandsixNeonatalI CUs. RangelFraustoMS,WiblinT,BlumbergHM ,etal. Clinical Infectious Diseases . 1999
  • [10] Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. Beck-Sague C,Jarvis WR. The Journal of Infectious Diseases . 1993